Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd. announced that it expects to receive CNY 130 million in funding from Hebei Jianxin Chemical Co., Ltd.
March 01, 2021
Share
Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd. announced that it will receive CNY 130,000,000 in an equity round of funding from returning investor Hebei Jianxin Chemical Co., Ltd. (SZSE:300107) on March 2, 2021. Post-closing, the registered capital will increase from CNY 20,000,000 to CNY 150,000,000 and the investor will retain its 100% stake in the company. The transaction has been approved by the board of directors of Hebei Jianxin Chemical Co., Ltd. (SZSE:300107) in its 11th meeting of 5th directorate and does not need approval from its shareholders.
Hebei Jianxin Chemical Co Ltd is a China-based company mainly engaged in the production and sales of benzene-based intermediate products. The Company's main product lines can be divided into composite material intermediates, pharmaceutical and pesticide intermediates, dye intermediates and paper chemicals. The Company's main products include m-aminobenzenesulfonic acid, aniline-2,5-disulfonic acid monosodium salt, m-hydroxy-N, N-diethylaniline, m-aminophenol, ODB-2, Jianxin201, 4,4'-Diaminodiphenyl sulfone, 4,4'-dichlorodiphenyl sulfone, 3,3'-diaminodiphenyl sulfone, among others. The Company's products are mainly used in medicine, composite materials, dyes, papermaking and other fields. The Company's products are distributed to domestic and overseas markets.
Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd. announced that it expects to receive CNY 130 million in funding from Hebei Jianxin Chemical Co., Ltd.
HEBEI JIANXIN CHEMICAL CO., LTD. 
